Peer Review History
| Original SubmissionFebruary 15, 2021 |
|---|
|
PONE-D-21-03373Effectiveness of birth plan counselling based on share decision making: a cluster randomized controlled trial (APLANT)PLOS ONE Dear Dr. López-Gimeno, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been evaluated by three reviewers, and their comments are available below. The reviewers have raised some minor concerns about the manuscript. Specifically, they feel the manuscript requires additional work in clarifying the theoretical basis for the study, particularly noting the need for greater attention to the conceptual definitions in the Introduction. In addition, they request further detail in the methodology and statistical analyses. Language editing is also recommended for this submission. Could you please carefully revise the manuscript to address all comments raised? Please submit your revised manuscript by Nov 25 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Avanti Dey, PhD Staff Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. 3. While we appreciate that you have included a patient flow diagram in Figure 1, we request that you please use the CONSORT flow diagram to illustrate your study, available at http://www.consort-statement.org/consort-statement/flow-diagram 4. Thank you for submitting your clinical trial to PLOS ONE and for providing the name of the registry and the registration number. The information in the registry entry suggests that your trial was registered after patient recruitment began. PLOS ONE strongly encourages authors to register all trials before recruiting the first participant in a study. As per the journal’s editorial policy, please include in the Methods section of your paper: a) your reasons for your delay in registering this study (after enrolment of participants started); b) confirmation that all related trials are registered by stating: “The authors confirm that all ongoing and related trials for this drug/intervention are registered 5. Thank you for stating in your Funding Statement: "The trial was funded partially by the “Nurse and Society Foundation” as part of the Nurse Research Projects Grants (PR-224/2017), Barcelona (Spain): EL, GS, MV,LB, GV, GF https://www.infermeriaisocietat.cat/ As well by the “Grant XB. Barcelona, Research modules, 10th Edition”, Institut Català de la Salut”, Spain 2018: EL, GV https://atencioprimariaicsbcn.files.wordpress.com/2019/05/jornada_de_recerca_resultats_ajuts_xb_2019.pdf .The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 6. Thank you for stating the following financial disclosure: "The trial was funded partially by the “Nurse and Society Foundation” as part of the Nurse Research Projects Grants (PR-224/2017), Barcelona (Spain): EL, GS, MV,LB, GV, GF https://www.infermeriaisocietat.cat/ As well by the “Grant XB. Barcelona, Research modules, 10th Edition”, Institut Català de la Salut”, Spain 2018: EL, GV https://atencioprimariaicsbcn.files.wordpress.com/2019/05/jornada_de_recerca_resultats_ajuts_xb_2019.pdf .The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." We note that one or more of the authors is affiliated with the funding organization, indicating the funder may have had some role in the design, data collection, analysis or preparation of your manuscript for publication; in other words, the funder played an indirect role through the participation of the co-authors. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please do the following: a. Review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. These amendments should be made in the online form. b. Confirm in your cover letter that you agree with the following statement, and we will change the online submission form on your behalf: “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: A two-arm controlled randomized cluster designed trial was conducted to compare Mackey Satisfaction with Childbirth Rating Scale between intervention of shared decision making to standard midwife counseling. Satisfaction ratings of the birth plan were similar between the two groups. Minor revisions: 1- Lines 217, 262, 280, 308 & 315: Correct typographical error: “Fisher’s exact test.” 2- Line 219: Specify the statistical methods used for the multivariate analysis. 3- Indicate the date range subjects were enrolled in the study. 4- State and justify the study’s target sample size with a pre-study statistical power calculation. The power calculation should include: sample size, alpha level (indicating one or two-sided), minimal detectable difference and statistical testing method. 5- Table 4: Clarify if the ANOVA method or logistic regression was used for the analysis. 6- Clarify that results in Table 5 are derived from univariate models. Specify the statistical methods used to generate the results. 7- Table 6: Specify the criteria for determining which variables were retained in the multivariate model. 8- Indicate if any adverse events occurred during the course of the study. Reviewer #2: Very well-designed research, with findings that correspond to the objectives of the study, especially with regard to the use of humanized care methodologies. Experimental research very well outlined in the method section. Very little possibility that there was no differentiation between the control and experimental groups, which validates the results. Reviewer #3: Review Plos One-D-21-03373 Effectiveness of birth plan counselling based on share decision making: a cluster randomized controlled trial (APLANT) Overall This is an interesting article, which presents the findings of RCT on a relevant topic. More insight into the use of birth plans and SDM has the potential to improve women’s childbirth experiences, but limited research has been done. This study helps to fill this gap. Overall, the research is sound. However, on certain points it needs more clarity and further explaining. This can partly be achieved by improving the language. The English used in this article needs improvement: certain choice of words is unclear, sentences are unfinished and it is not always clear to what ‘they’ or ‘this’ is referring to. I will give some examples in my detailed feedback, but they are not all inclusive. The article needs to be clearer on the analyses that have been done, especially with regard to intention-to-treat and per protocol analyses. Detailed feedback Abstract The background needs more clarity. What is exactly the aim of the study? In the methods, it needs to be clear where the two approaches differ. That the CG also received the BP and counseling, but the counseling was not based on SDM and there was no leaflet. I would state that the MSCRS was used to measure the primary outcome. I suggest replacing Findings with Results. In the article itself you also use the word Results, which is more appropriate for an RCT. ‘That’ should be added in the sentence “The results showed that women of the IG …” Add ‘in the IG’ to the ‘sentence “…, the satisfaction with childbirth experience was high in the IG and similar. I have difficulty with the firm statement: Women who presented BP had a greater probability of spontaneous vaginal birth aOR=2.07 (95% CI: 1.23-3.5) and early skin-to-skin contact aOR=2.29 (95% CI: 1.2-4.2). This is a per protocol analysis, where it is not known if groups are comparable. There is no correction for possible confounders, such as parity. In the conclusion, pharmacological and non-pharmacological methods for pain relief are mentioned, but not the difference in epidural. Throughout the article, there is an inconsistency in presenting these variables. Sometimes only epidural is mentioned, sometimes only the combination of pharmaceutical and non-pharmaceutical. And occasionally both. Introduction Line 77: I would replace ‘aspects’ with the word ‘choices’. Introduce abbreviation like SDM and BP by writing them in full when using them for the first time in the article. Line 78-81: I suggest replacing the women (=line 79) with a woman as midwife is also single. Line 83: replace ‘with’ with ‘in’. Line 84: replace ‘of’ with ‘about’. Line 88: what is meant by ‘… for focusing discussion …”? Line 89: it is Afshar et al. Line 90: Epstein model. There are many models for SDM, please explain this model a bit further, e.g. in a Box. Line 93: ‘… to the person …’, what person is meant? Line 101: Here you refer to reference 16 and 17, in the discussion to 20 and 21. Please make this consistent. Line 103-105: Please, elaborate here what this means for the BP. And how women present their BP they go to the hospital when they are in labor. Line 107: words are missing after ‘… evaluates the …’. Line 112-114: make clearer that this accounts for the group who have actually presented the BP (with or without the intervention). This nuance is hard to capture when you are not familiar with the study. Line 115: replace ‘make up’ with ‘are’. Methods Line 121-122: Contamination is a good point. Is it also very unlikely that women of the different groups are in touch with each other? Line 133: how were the midwives of the CG group informed about the situation, were they aware that midwives in the IG received instruction around SDM? Line 195-196: Who filled out the data collection form? This should be indicated. Line 203: How did the women report these data and when? There should be information about this in the text. Line 212: add to the end of this sentence ‘…with higher scores indicating higher satisfaction’. Line 213: In this section, there should also be information about the type of analysis in this RCT: was it intention-to-treat? Apparently there was also a per protocol analysis. This information needs to be in this section as well. Line 2014: ‘introduced’ is not the right word. Line 222: how was level of obstetric risk defined? Results Line 251 and 252. Apparently, CS were excluded. This should be motivated in the methods section. Line 258: replace ‘greater’ with ‘higher’. Line 259: elaborate from which countries these women came, e.g. from high income or middle/low income countries? Table 1: why no information on parity? Table 2: Participation in decision making in first and second stage. How was this measured? What do the given numbers mean? There is no information in the method section. Line 287: ‘… differences were not statistically significant.’ And how clinical relevant is a difference of 3 points on a scale that scores up to 175? Emphasizing the difference is not relevant. Line 304-306: what do we know of women's intention to breastfeed? Does this perhaps explain the difference? Table 4: why was parity not included as a possible confounder? Table 5 and line 328-330: how comparable were the two groups? This is a per protocol analysis. Why is this not corrected for confounders, such as parity, etc.? This is really necessary to understand the meaning of these outcomes. Discussion Line 341-342: why is pharmaceutical and non-pharmaceutical pain relief not mentioned here? Line 346: add ‘, which was 67% in 2016’ after Department. Line 348: what is meant by shared based counseling? Is it double with based on SDM? Line 348: replace ‘would be’ with ‘is’. Line 351-352: sentence is not complete. Line 352-356: why is not mentioned that it was one hospital especially where BP were not presented? Line 364: elevated compared to what? If you mean high, that give information on what this qualification is based. We know from other research that women score high on satisfaction directly after birth (compared to later in time) and that is influenced by culture. Line 367: add ‘such’ after ‘[30],’. Line 368-370: sentence doesn't run well, it now suggests that sdm is related with greater satisfaction with sdm process. Line 375: replace ‘they’ with ‘the participating women’. Line 384-386: This needs some further explaining. This is a per protocol analysis and the groups might be different. I think it is debatable if these findings are due to the presentation of the BP, other mechanism might be at work like parity. Also early skin-to-skin and breastfeeding might be explained by more vaginal births. Line 388-391: how is this related to your findings? Line 412: where does PtADs stand for? Line 417: and epidurals? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-03373R1Effectiveness of birth plan counselling based on share decision making: a cluster randomized controlled trial (APLANT)PLOS ONE Dear Dr. López-Gimeno, Thank you for submitting your manuscript to PLOS ONE - please accept our apologies for the time it has taken to complete this round of the peer review process. After careful consideration, we feel that your manuscript has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been evaluated again by three reviewers, and their comments are available below. The reviewers feel that the manuscript has improved in the latest version, but they have requested some additional clarifications on some aspects of the methodology and suggested some linguistic changes. Could you please revise the manuscript to carefully address the concerns raised? Please submit your revised manuscript by Jun 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
We look forward to receiving your revised manuscript. Kind regards, Joseph Donlan Editorial Office PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Minor revisions: 1- Lines 68 and 326: Provide a measure of dispersion for the values 150.2 and 153.4 and identify the type of summary statistics these numbers represent, ie., mean, median, etc. 2- Lines 254 and 259: Clarify the type of statistical method used for the bivariate analysis and whether the presentation of BP to the hospital was related to the obstetrics outcomes and grade of satisfaction of women. 3- Line 261: Drop “non-parametric test of” from the statement, “For comparison of categorical variables, the non-parametric test of Fisher’s exact test was used.” 4- Line 262: Consider replacing the sentence at line 262 with the following one. To compare quantitative variables, Student’s t-test, ANOVA test, or the Mann-Whitney U test was used. 5- Line 268: Clarify if this statement implies that these are univariate analyses. “To determine which obstetric variables (type of birth, epidural, methods of pain relief, breastfeeding in delivery room, early skin-to-skin contact, maternal and neonatal complications) could have a joint relation with presenting the birth plan, we carried out another logistic regression model.” 6- Line 271: Clarify if the following statement implies that a multivariate analysis was conducted. “The model was adjusted by variables clinically relevant or who had a level of significance <0.05 in the bivariate analysis (belonging to the control group or intervention group, age, country of origin, education, previous births,).” 7- Line 272: Typically variables with univariate p-values < 0.20 are included as candidate predictors in multivariate logistic regression models where perhaps stepwise regression is conducted to reduce the model to the most predictive factors. 8- Line 297: Consider replacing “basal” with “baseline.” 9- Table 1: A- Define SD. Keep consistent notation throughout the manuscript. B- Express p-values of 1 as 1.0, in Table 1 and throughout the manuscript. C- Typographical error for p < 0.0001 for comparing proportions in various education categories. 11- Table 4: Perhaps the statistical testing method for comparing age in the two groups can be referred to as a Student’s t-test. ANOVA is typically used when comparing means in more than two groups and it reduces to a Student's t-test when comparing two groups. 12- Explain why stepwise logistic regression was used. Perhaps candidate predictors as identified by univariate analyses were selected using stepwise logistic regression. However, this point has not been clearly communicated. ***Note that line numbering refers to those in the tracked changes version of revision 1. Reviewer #2: I have not comments to your article that is very good and meaningful for midwifery care. The birth plan has proved to be an instrument of great value, especially in countries (such as Brazil) where the care model is still interventionist and therefore does not consider the wishes of the woman. Reviewer #3: The authors have addressed the comments adequately and the article is now much clearer. There are still some issues that need consideration. Line 58: Add here that midwives did the counseling in the IG. Line 66-67: This sentence does not read well. Line 70: ‘Likewise’ is not correct here. Line 86: A ‘d’ is missing after ‘share’. Line 145-146: be clearer what is meant by ‘this’. Suggestion: ‘This later registration …’ Line 190: It should be SDM not SMD. Line 217: Here the actual obstetric outcomes should be named and why those were chosen. Also the ‘combined non-pharmacological and pharmacological methods’ should be explained more. What does this involve? Line 254-258: The description is not very clear. Line 262: ‘quantitative variables’ is not the right term, also categorical variables are quantitative. Line 375: There needs to be an ‘s’ at the end of ‘confounder’. Line 380: I suggest using ‘compared’ instead of ‘with respect’. Line 409: It is Elwyn not Ewlyn. Line 447: Knowledge does not need a capital K. Line 470: I suggest starting a new sentence after hospital. The language issues I mention are just an indication. The article still can use further improvement of the English language. I suggest asking a native speaking (with a science background) to have a look at it. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Effectiveness of birth plan counselling based on shared decision making: a cluster randomized controlled trial (APLANT) PONE-D-21-03373R2 Dear Dr. López-Gimeno, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, James Mockridge Staff Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-21-03373R2 Effectiveness of birth plan counselling based on shared decision making: a cluster randomized controlled trial (APLANT) Dear Dr. López-Gimeno: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr James Mockridge Staff Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .